Littelfuse, Inc. (NASDAQ:LFUS) Given Average Rating of “Moderate Buy” by Analysts
Littelfuse, Inc. (NASDAQ:LFUS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective […]
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Rating of “Hold” from Analysts
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus rating of “Hold” from the sixteen analysts that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, eleven have issued a hold recommendation, three have given a buy recommendation and one has […]
Kimball Electronics, Inc. (NASDAQ:KE) Receives Consensus Rating of “Moderate Buy” from Brokerages
Kimball Electronics, Inc. (NASDAQ:KE – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the […]
Critical Analysis: Avidity Biosciences (NASDAQ:RNA) and MacroGenics (NASDAQ:MGNX)
MacroGenics (NASDAQ:MGNX – Get Free Report) and Avidity Biosciences (NASDAQ:RNA – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations. Profitability This table compares MacroGenics and Avidity Biosciences’ […]
last updated on 21 Sep 00:01